These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 31606990)
21. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Chung KW; Yang SK; Lee GK; Kim EY; Kwon S; Lee SH; Park DJ; Lee HS; Cho BY; Lee ES; Kim SW Clin Endocrinol (Oxf); 2006 Nov; 65(5):660-6. PubMed ID: 17054470 [TBL] [Abstract][Full Text] [Related]
23. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation. Kwon HJ; Kim EK; Kwak JY Pathol Res Pract; 2015 Sep; 211(9):671-6. PubMed ID: 26187369 [TBL] [Abstract][Full Text] [Related]
24. Fine-needle Aspiration Washout Precipitation Specimens: An Acceptable Supplement to Genetic Mutation Detection of Thyroid Nodules. Cui Y; Huang X; Guo J; Zhang N; Liang J; Zhang Y; Liao Y; He D Technol Cancer Res Treat; 2021; 20():15330338211057982. PubMed ID: 34806478 [No Abstract] [Full Text] [Related]
25. Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing. Paskaš S; Janković J; Živaljević V; Tatić S; Božić V; Nikolić A; Radojković D; Savin S; Cvejić D Cancer Cytopathol; 2015 Aug; 123(8):471-9. PubMed ID: 25924719 [TBL] [Abstract][Full Text] [Related]
26. Preoperative BRAF(V600E) mutation screening is unlikely to alter initial surgical treatment of patients with indeterminate thyroid nodules: a prospective case series of 960 patients. Kleiman DA; Sporn MJ; Beninato T; Crowley MJ; Nguyen A; Uccelli A; Scognamiglio T; Zarnegar R; Fahey TJ Cancer; 2013 Apr; 119(8):1495-502. PubMed ID: 23280049 [TBL] [Abstract][Full Text] [Related]
27. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of Cho YY; Park SY; Shin JH; Oh YL; Choe JH; Kim JH; Kim JS; Yim HS; Kim YL; Ki CS; Kim TH; Chung JH; Kim SW Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781560 [TBL] [Abstract][Full Text] [Related]
28. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study. Rossi M; Buratto M; Bruni S; Filieri C; Tagliati F; Trasforini G; Rossi R; Beccati MD; Degli Uberti EC; Zatelli MC J Clin Endocrinol Metab; 2012 Jul; 97(7):2354-61. PubMed ID: 22535974 [TBL] [Abstract][Full Text] [Related]
29. Diagnostic value of B-RAF(V600E) in difficult-to-diagnose thyroid nodules using fine-needle aspiration: systematic review and meta-analysis. Jia Y; Yu Y; Li X; Wei S; Zheng X; Yang X; Zhao J; Xia T; Gao M Diagn Cytopathol; 2014 Jan; 42(1):94-101. PubMed ID: 24167125 [TBL] [Abstract][Full Text] [Related]
30. Proper indication of BRAF(V600E) mutation testing in fine-needle aspirates of thyroid nodules. Koh J; Choi JR; Han KH; Kim EK; Yoon JH; Moon HJ; Kwak JY PLoS One; 2013; 8(5):e64505. PubMed ID: 23717622 [TBL] [Abstract][Full Text] [Related]
34. Real-life utility of five-gene panel test in preoperative thyroid fine-needle aspiration biopsy: a large cohort of 740 patients study. Tang J; Ma J; Xi X; Wang L; Li H; Huo S; Zhang B Endocrine; 2023 Jun; 80(3):552-562. PubMed ID: 36542267 [TBL] [Abstract][Full Text] [Related]
35. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma". Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827 [TBL] [Abstract][Full Text] [Related]
36. [Diagnostic values of BRAF(V600E) mutation analysis and Bethesda system for reporting thyroid cytopathology in thyroid nodules with TIRADS 4 and 5]. Han Y; Zhao BW; Li SY; Lyu JG; Shou JD; Xu HS; Lou HY; Xu LL; Gao L; Xu SX; Zhu J Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Sep; 52(9):686-691. PubMed ID: 28910894 [No Abstract] [Full Text] [Related]
37. Is follow-up BRAF(V600E) mutation analysis helpful in the differential diagnosis of thyroid nodules with negative results on initial analysis? Yoon JH; Kim EK; Moon HJ; Kwak JY PLoS One; 2013; 8(3):e58592. PubMed ID: 23505540 [TBL] [Abstract][Full Text] [Related]
38. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR. Kwak JY; Han KH; Yoon JH; Kim EK; Moon HJ; Kim YL; Park SJ; Choi JR Ann Clin Lab Sci; 2012; 42(3):258-65. PubMed ID: 22964613 [TBL] [Abstract][Full Text] [Related]
39. Diagnostic Limitation of Fine-Needle Aspiration (FNA) on Indeterminate Thyroid Nodules Can Be Partially Overcome by Preoperative Molecular Analysis: Assessment of RET/PTC1 Rearrangement in BRAF and RAS Wild-Type Routine Air-Dried FNA Specimens. Ko YS; Hwang TS; Kim JY; Choi YL; Lee SE; Han HS; Kim WS; Kim SK; Park KS Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417935 [TBL] [Abstract][Full Text] [Related]
40. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration. Moon HJ; Kim EK; Chung WY; Choi JR; Yoon JH; Kwak JY Ann Surg Oncol; 2011 Mar; 18(3):792-9. PubMed ID: 20945104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]